Cargando...
Monitoring Toxicity, Impact, and Adherence of Hydroxyurea in Children with Sickle Cell Disease
Hydroxyurea (HU) is underutilized in sickle cell disease (SCD). Patient adherence with taking HU and with required drug monitoring is a provider perceived barrier to HU utilization.(1-4) To determine process issues that may contribute to these barriers we sought to: 1) describe how providers monitor...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804029/ https://ncbi.nlm.nih.gov/pubmed/21815183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.22101 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|